Evidence map›Paper›PMID 37422624›Full record

ArticleBMC cancer2023

Deep learning-based radiomic nomograms for predicting Ki67 expression in prostate cancer.

Shuitang Deng, Jingfeng Ding, Hui Wang, Guoqun Mao, Jing Sun, Jinwen Hu, Xiandi Zhu, Yougen Cheng, Genghuan Ni, Weiqun Ao

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Multimodal ultrasound-based radiomics and deep learning for differential diagnosis of O-RADS 4-5 adnexal masses.Cancer imaging : the official publication of the International Cancer Imaging Society · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Shuitang Deng *Department of Radiology, Tongde Hospital of Zhejiang Province, No. 234 Gucui Road, Zhejiang Province, 310012, Hangzhou, China.
Jingfeng Ding *Department of Radiology, Shanghai Putuo District People's Hospital, Shanghai, China.
Hui WangDepartment of Radiology, Tongde Hospital of Zhejiang Province, No. 234 Gucui Road, Zhejiang Province, 310012, Hangzhou, China.
Guoqun MaoDepartment of Radiology, Tongde Hospital of Zhejiang Province, No. 234 Gucui Road, Zhejiang Province, 310012, Hangzhou, China.
Jing SunDepartment of Radiology, Shanghai Putuo District People's Hospital, Shanghai, China.
Jinwen HuDepartment of Radiology, Shanghai Putuo District People's Hospital, Shanghai, China.
Xiandi ZhuDepartment of Radiology, Tongde Hospital of Zhejiang Province, No. 234 Gucui Road, Zhejiang Province, 310012, Hangzhou, China.
Yougen ChengDepartment of Radiology, Tongde Hospital of Zhejiang Province, No. 234 Gucui Road, Zhejiang Province, 310012, Hangzhou, China.
Genghuan NiDepartment of Radiology, The Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang Province, China.
Weiqun AoDepartment of Radiology, Tongde Hospital of Zhejiang Province, No. 234 Gucui Road, Zhejiang Province, 310012, Hangzhou, China. 78123858@qq.com.
Tongde Hospital of Zhejiang Province · CNCentral Hospital of Putuo District · CNJiaxing University · CN

Funding

Medical Science and Technology Project of Zhejiang Province 2019RC028Medical Science and Technology Project of Zhejiang Province 2023KY079
6 · The paper itself

Abstract

backgroundTo explore the value of a multiparametric magnetic resonance imaging (MRI)-based deep learning model for the preoperative prediction of Ki67 expression in prostate cancer (PCa). MATERIALS: The data of 229 patients with PCa from two centers were retrospectively analyzed and divided into training, internal validation, and external validation sets. Deep learning features were extracted and selected from each patient's prostate multiparametric MRI (diffusion-weighted imaging, T2-weighted imaging, and contrast-enhanced T1-weighted imaging sequences) data to establish a deep radiomic signature and construct models for the preoperative prediction of Ki67 expression. Independent predictive risk factors were identified and incorporated into a clinical model, and the clinical and deep learning models were combined to obtain a joint model. The predictive performance of multiple deep-learning models was then evaluated.

resultsSeven prediction models were constructed: one clinical model, three deep learning models (the DLRS-Resnet, DLRS-Inception, and DLRS-Densenet models), and three joint models (the Nomogram-Resnet, Nomogram-Inception, and Nomogram-Densenet models). The areas under the curve (AUCs) of the clinical model in the testing, internal validation, and external validation sets were 0.794, 0.711, and 0.75, respectively. The AUCs of the deep models and joint models ranged from 0.939 to 0.993. The DeLong test revealed that the predictive performance of the deep learning models and the joint models was superior to that of the clinical model (p < 0.01). The predictive performance of the DLRS-Resnet model was inferior to that of the Nomogram-Resnet model (p < 0.01), whereas the predictive performance of the remaining deep learning models and joint models did not differ significantly.

conclusionThe multiple easy-to-use deep learning-based models for predicting Ki67 expression in PCa developed in this study can help physicians obtain more detailed prognostic data before a patient undergoes surgery.

Indexed as

Deep LearningProstatic NeoplasmsHumansKi-67 AntigenMagnetic Resonance ImagingMaleNomogramsRetrospective StudiesKi-67 AntigenDeep learningKi67PrognosisProstate cancer

Identifiers

PMID37422624
PMCPMC10329306
OpenAlexW4383620452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.